mb glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Arrae MB-1 - 30 Servings
Description
The MHRA has issued a Drug Safety Update recommending B12 monitoring in patients on long-term metformin treatment
Nat Killer T Cell Divers Immunotherapy Cancers 2023;15
doi: 10.3390/nu7020730
Also, LBM reduction was often assessed using BIA or DXA, both of which have limitations in distinguishing between muscle, organ mass, and extracellular fluid
The most commonly reported adverse events were nausea, diarrhea, and vomiting
